The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School: Cognitive Dysfunction trials

The registry lists 13 Cognitive Dysfunction studies with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 3 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive ImpairmentRecruitingNCT07650318Not applicable
• Transcutaneous Auricular Vagus Nerve Stimulation in Type 2 Diabetes With Mild Cognitive ImpairmentNot yet recruitingNCT07642518Not applicable
• Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)RecruitingNCT07083154Phase 3
• China Diabetes Cognitive Dysfunction Early Diagnosis and Intervention Study (China-DECODE Study)RecruitingNCT06650969
• Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma BiomarkersRecruitingNCT06561906
• Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM PatientsRecruitingNCT06217887Not applicable
• Risk Model of Cognitive Impairment in DiabetesRecruitingNCT05590442
• Relationship and Central Mechanism Between Diabetes and Cognitive Impairment Based on Simultaneous EEG-fMRI Approach and Peripheral Neuropathology Biomarkers AssayRecruitingNCT05545657
• Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive ImpairmentRecruitingNCT05543967
• Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive ImpairmentCompletedNCT06327633Not applicable
• Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical TrialCompletedNCT06085703Not applicable
• LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 DiabetesCompletedNCT05313529Not applicable
• Relationship Between Diabetes and Cognitive Impairment Based on Olfactory Function Assessment and Functional MRICompletedNCT02738671